Oral Hammaslaakarit Oyj Stock

Stocks

Delayed Nasdaq Helsinki			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

Manager	Title	Age	Since
Jarkko Olavi Jokinen CEO	Chief Executive Officer	-	2019-05-31
Thomas Mount DFI	Director of Finance/CFO	-	-
Petra Kari CTO	Chief Tech/Sci/R&D Officer	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORAL HAMMASLAAKARIT OYJ	-.--%	-.--%	-	-	0
CVS HEALTH CORPORATION	-1.29%	-5.07%	+9.10%	+35.69%	117B
HCA HEALTHCARE, INC.	+2.95%	-0.54%	-0.99%	+105.61%	97.42B
NATERA, INC.	+3.31%	+4.56%	+120.80%	+1,009.30%	59.22B
FRESENIUS SE & CO. KGAA	+0.17%	+2.97%	-6.19%	+89.51%	29.03B
LABCORP HOLDINGS INC.	+8.78%	+11.49%	+30.69%	+81.07%	26.86B
QUEST DIAGNOSTICS INCORPORATED	+1.26%	+3.58%	+36.26%	+92.37%	26.69B
TENET HEALTHCARE CORPORATION	+2.46%	-1.40%	+24.21%	+405.46%	21.1B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.95%	+2.20%	-16.82%	-0.93%	20.61B
IHH HEALTHCARE	-0.13%	-1.01%	-6.23%	+31.16%	16.94B
Average	+2.06%	-0.26%	+21.20%	+205.47%	46.05B
Weighted average by Cap.	+2.25%	-1.40%	+23.62%	+218.43%